Clincosm LogoSign in Get a demo

pancreas cancer

Showing NaN - NaN of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • +17 more
  • San Diego, California
  • +3 more
Jan 27, 2023

Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

Not yet recruiting
  • Pancreas Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Aug 15, 2022

HLA Typing and Tumor Neoantigen Identification forPhase I/II

Recruiting
  • Ovarian Cancer
  • +5 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Pancreatic Cancer Early Detection Consortium

    Recruiting
    • Pancreas Cancer
    • +3 more
      • Duarte, California
      • +29 more
      Jul 14, 2022

      Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

      Recruiting
      • Solid Tumor, Adult
      • +11 more
      • New Haven, Connecticut
      • +3 more
      May 9, 2022

      Long-term, Non-interventional, Observational Study Following

      Recruiting
      • Advanced Solid Tumor
      • +17 more
      • Allogeneic natural killer (NK) cell
      • San Diego, California
      • +3 more
      Oct 15, 2021

      Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

      Completed
      • Cancer
      • +18 more
      • ASN007: ascending doses
      • ASN007 RD
      • Tampa, Florida
      • +4 more
      Jul 7, 2020

      Pancreas Cancer Trial in India, United States (GI-4000, Gemcitabine)

      Completed
      • Pancreas Cancer
      • Birmingham, Alabama
      • +27 more
      Apr 2, 2015